Q-omics provides the consensus-scored COL11A2P1 profile across patient tissues and cancer cell-line models. COL11A2P1 expression is associated with patient survival in 10 of 34 cancer types, with the highest sampling consensus in THYM. Additionally, COL11A2P1 RNA expression shows 5,561 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight THYM, and STAD as cancer lineages where COL11A2P1 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.